Helsinn and Mundipharma China Pharmaceutical jointly announce NMPA’s approval of the oral formulation of Akynzeo® in China

    NEXT STORY
    Roche ranked as one of the most sustainable healthcare companies in the Dow Jones Sustainability Indices for the eleventh year running
    PREV STORY
    Lundbeck to acquire Alder BioPharmaceuticals – a company committed to transforming migraine treatment and prevention – in a transaction valued at up to USD 1.95 billion net of cash
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Spero Therapeutics Provides Update on SPR720 Phase 2a Clinical Trial

    author_avatar
    NASDAQ Market News

    FDA Advisory Committee Votes That Efficacy Results of Cempra’s Solithromycin Outweigh Risks for Community-Acquired Bacterial Pneumonia

    —FDA PDUFA dates December 27 & 28, 2016— CHAPEL HILL, N.C., Nov. 04, 2016 ...

    author_avatar
    NASDAQ Market News

    Lexington Biosciences Engages Clinical Research Organization

    VANCOUVER, BC--(Marketwired - Nov 30, 2017) - Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) ...

    author_avatar
    NASDAQ Market News